|
TMED10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.26050281323842E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28540000865485E-09 |
| Normal-vs-Stage2 |
1.256750E-03 |
| Normal-vs-Stage3 |
6.51034781640192E-13 |
| Normal-vs-Stage4 |
1.99518179755387E-12 |
| Stage1-vs-Stage2 |
1.190410E-01 |
| Stage1-vs-Stage3 |
2.413900E-02 |
| Stage1-vs-Stage4 |
1.002290E-03 |
| Stage2-vs-Stage3 |
3.021000E-03 |
| Stage2-vs-Stage4 |
7.427200E-04 |
| Stage3-vs-Stage4 |
2.985200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.43947093028873E-13 |
| Normal-vs-AfricanAmerican |
9.171100E-04 |
| Normal-vs-Asian |
1.74649961159901E-10 |
| Caucasian-vs-AfricanAmerican |
4.836000E-01 |
| Caucasian-vs-Asian |
3.478200E-01 |
| AfricanAmerican-vs-Asian |
2.864000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.29349922071287E-11 |
| Normal-vs-Female |
1.34209976465627E-10 |
| Male-vs-Female |
3.951200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.60929960865997E-10 |
| Normal-vs-Age(41-60Yrs) |
4.45260495141042E-11 |
| Normal-vs-Age(61-80Yrs) |
1.63050000168141E-08 |
| Normal-vs-Age(81-100Yrs) |
6.755700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.515600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.639800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.112200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.403400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.989400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.692800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.57119999999856E-05 |
| Classical-VS-Follicular |
2.806200E-02 |
| Classical-VS-Other |
1.988220E-01 |
| Classical-VS-Normal |
5.62494495426336E-12 |
| Tall-VS-Follicular |
1.26609999995253E-06 |
| Tall-VS-Other |
7.737000E-01 |
| Tall-VS-Normal |
1.23234755733392E-14 |
| Follicular-VS-Other |
1.005230E-01 |
| Follicular-VS-Normal |
3.554000E-04 |
| Other-VS-Normal |
1.559840E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.07229999990466E-07 |
| Normal-vs-N1 |
4.84723372551343E-13 |
| N0-vs-N1 |
1.176380E-03 |
|
|
